Harte Hanks appoints David Fisher as president
Leadership Appointment: Harte Hanks has appointed David Fisher as President, recognizing his contributions since joining the company in March 2023 and his role in launching 'Project Elevate' aimed at enhancing EBITDA stability and service innovation.
Strategic Role: In his new position, Fisher will oversee daily operations and strategic execution, collaborating with the executive leadership team during a critical transformation phase for the company.
Trade with 70% Backtested Accuracy
Analyst Views on HHS
About HHS
About the author
Friday 12/6 Insider Buying Report: DMLP, HHS
Dorchester Minerals Insider Purchase: CFO Leslie A. Moriyama purchased 12,050 shares of DMLP for $414,640 at $34.41 each, while the stock is currently trading lower at $33.00, indicating a potential buying opportunity for investors.
Harte Hanks Insider Purchase: Director Bradley Louis Radoff bought 42,775 shares of Harte Hanks for $241,551 at $5.65 each, with the stock up about 3.6% on Friday, reflecting an 8.0% gain based on current trading prices.
Harte-Hanks (HHS) Q3 Earnings and Revenues Top Estimates
Earnings Performance: Harte-Hanks reported quarterly earnings of $0.13 per share, exceeding estimates and showing a year-over-year increase from $0.08. The company also surpassed revenue expectations with $47.63 million for the quarter.
Market Outlook: Despite recent earnings success, Harte-Hanks shares have underperformed compared to the S&P 500 this year, and the stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Integral Ad Science (IAS) Q3 Earnings Top Estimates
Earnings Performance: Integral Ad Science (IAS) reported quarterly earnings of $0.10 per share, exceeding estimates and showing improvement from a loss of $0.09 per share a year ago, although revenues fell short of expectations at $133.53 million.
Market Outlook: IAS shares have underperformed the market this year, with a Zacks Rank of #3 (Hold), indicating expected performance in line with the market; future stock movements will depend on management's commentary and earnings estimate revisions.
Harte-Hanks (HHS) Flat As Market Gains: What You Should Know
Harte-Hanks Stock Performance: Harte-Hanks (HHS) closed at $6.98, unchanged from the previous day, while experiencing a 5.55% loss over the past month, underperforming compared to the Business Services sector and S&P 500 gains. The company is set to release its earnings report on November 14, 2024, with expectations of a 25% year-over-year growth in earnings.
Analyst Estimates and Zacks Rank: The Zacks Consensus Estimates predict a significant decline in annual earnings and revenue for Harte-Hanks, currently holding a Zacks Rank of #3 (Hold). The Zacks Rank system indicates that stocks rated #1 (Strong Buy) have historically outperformed others, suggesting potential investment strategies based on analyst estimate changes.
Harte-Hanks (HHS) Stock Moves -0.68%: What You Should Know
Stock Performance: Harte-Hanks (HHS) closed at $7.25, down 0.68%, underperforming compared to the S&P 500 and other indices; the company has seen a 4.33% decline over the past month, while analysts expect an EPS of $0.10 in the upcoming earnings report.
Analyst Insights: The Zacks Rank system rates Harte-Hanks as #3 (Hold), reflecting stagnant EPS estimates, while the Advertising and Marketing industry ranks in the top 23% of all industries, indicating potential for future stock performance based on estimate revisions.
Harte-Hanks (HHS) Stock Falls Amid Market Uptick: What Investors Need to Know
Harte-Hanks Stock Performance: Harte-Hanks (HHS) closed at $7.30, down 0.41%, underperforming the S&P 500 and experiencing a 4.06% decline over the past month; upcoming earnings are projected to show a 25% increase in EPS year-over-year.
Analyst Forecasts and Zacks Rank: Analysts expect a challenging full year for Harte-Hanks with significant declines in earnings and revenue; the company currently holds a Zacks Rank of #3 (Hold), indicating average performance potential within the Advertising and Marketing industry.
Friday 12/6 Insider Buying Report: DMLP, HHS
Dorchester Minerals Insider Purchase: CFO Leslie A. Moriyama purchased 12,050 shares of DMLP for $414,640 at $34.41 each, while the stock is currently trading lower at $33.00, indicating a potential buying opportunity for investors.
Harte Hanks Insider Purchase: Director Bradley Louis Radoff bought 42,775 shares of Harte Hanks for $241,551 at $5.65 each, with the stock up about 3.6% on Friday, reflecting an 8.0% gain based on current trading prices.
Harte-Hanks (HHS) Q3 Earnings and Revenues Top Estimates
Earnings Performance: Harte-Hanks reported quarterly earnings of $0.13 per share, exceeding estimates and showing a year-over-year increase from $0.08. The company also surpassed revenue expectations with $47.63 million for the quarter.
Market Outlook: Despite recent earnings success, Harte-Hanks shares have underperformed compared to the S&P 500 this year, and the stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Integral Ad Science (IAS) Q3 Earnings Top Estimates
Earnings Performance: Integral Ad Science (IAS) reported quarterly earnings of $0.10 per share, exceeding estimates and showing improvement from a loss of $0.09 per share a year ago, although revenues fell short of expectations at $133.53 million.
Market Outlook: IAS shares have underperformed the market this year, with a Zacks Rank of #3 (Hold), indicating expected performance in line with the market; future stock movements will depend on management's commentary and earnings estimate revisions.
Harte-Hanks (HHS) Flat As Market Gains: What You Should Know
Harte-Hanks Stock Performance: Harte-Hanks (HHS) closed at $6.98, unchanged from the previous day, while experiencing a 5.55% loss over the past month, underperforming compared to the Business Services sector and S&P 500 gains. The company is set to release its earnings report on November 14, 2024, with expectations of a 25% year-over-year growth in earnings.
Analyst Estimates and Zacks Rank: The Zacks Consensus Estimates predict a significant decline in annual earnings and revenue for Harte-Hanks, currently holding a Zacks Rank of #3 (Hold). The Zacks Rank system indicates that stocks rated #1 (Strong Buy) have historically outperformed others, suggesting potential investment strategies based on analyst estimate changes.
Harte-Hanks (HHS) Stock Moves -0.68%: What You Should Know
Stock Performance: Harte-Hanks (HHS) closed at $7.25, down 0.68%, underperforming compared to the S&P 500 and other indices; the company has seen a 4.33% decline over the past month, while analysts expect an EPS of $0.10 in the upcoming earnings report.
Analyst Insights: The Zacks Rank system rates Harte-Hanks as #3 (Hold), reflecting stagnant EPS estimates, while the Advertising and Marketing industry ranks in the top 23% of all industries, indicating potential for future stock performance based on estimate revisions.
Harte-Hanks (HHS) Stock Falls Amid Market Uptick: What Investors Need to Know
Harte-Hanks Stock Performance: Harte-Hanks (HHS) closed at $7.30, down 0.41%, underperforming the S&P 500 and experiencing a 4.06% decline over the past month; upcoming earnings are projected to show a 25% increase in EPS year-over-year.
Analyst Forecasts and Zacks Rank: Analysts expect a challenging full year for Harte-Hanks with significant declines in earnings and revenue; the company currently holds a Zacks Rank of #3 (Hold), indicating average performance potential within the Advertising and Marketing industry.
